Literature DB >> 19860574

Treatment of complicated skin and soft tissue infections.

Addison K May1, Renae E Stafford, Eileen M Bulger, Daithi Heffernan, Oscar Guillamondegui, Grant Bochicchio, Soumitra R Eachempati.   

Abstract

BACKGROUND: Skin and soft tissue infections (SSTIs) may produce substantial morbidity and mortality rates, particularly those classified as complicated or necrotizing.
OBJECTIVE: To weigh the strength of recommendations using the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) methodology and to provide evidence-based recommendations for diagnosis and management for SSTIs. DATA SOURCES: Computerized identification of published research and review of relevant articles. STUDY SELECTION: All published reports on the management of complicated and necrotizing SSTIs were evaluated by an expert panel of members of the Surgical Infection Society according to published guidelines for evidence-based medicine. The quality of the evidence was judged by the GRADE methodology and criteria. Practice surveys, pharmacokinetic studies, and reviews or duplicative publications presenting primary data already considered were excluded from analysis. DATA EXTRACTION: Information on demographics, study dates, microbiology findings, antibiotic type, surgical interventions, infection-related outcomes, and the methodologic quality of the studies was extracted. Results were submitted to the Therapeutic Agents Committee of the Surgical Infection Society for review prior to creation of the final consensus document. DATA SYNTHESIS: Current surgical and antibiotic management of complicated SSTIs is based on a small number of studies that often have insufficient power to draw well-supported conclusions, with the exception of antimicrobial therapy for non-necrotizing soft tissue infections, for which ample data are available.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19860574     DOI: 10.1089/sur.2009.012

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  22 in total

Review 1.  Evaluation and Management of Necrotizing Soft Tissue Infections.

Authors:  Stephanie L Bonne; Sameer S Kadri
Journal:  Infect Dis Clin North Am       Date:  2017-09       Impact factor: 5.982

2.  [Postoperative necrotizing fasciitis: a rare and fatal complication].

Authors:  Hassen Ben Ghezala; Najla Feriani
Journal:  Pan Afr Med J       Date:  2016-03-24

Review 3.  Management and Novel Adjuncts of Necrotizing Soft Tissue Infections.

Authors:  Christine S Cocanour; Phillip Chang; Jared M Huston; Charles A Adams; Jose J Diaz; Charles B Wessel; Bonnie A Falcione; Graciela M Bauza; Raquel A Forsythe; Matthew R Rosengart
Journal:  Surg Infect (Larchmt)       Date:  2017-04-04       Impact factor: 2.150

4.  Bacterial contamination of surgical suture resembles a biofilm.

Authors:  Michelle J Henry-Stanley; Donavon J Hess; Aaron M T Barnes; Gary M Dunny; Carol L Wells
Journal:  Surg Infect (Larchmt)       Date:  2010-10       Impact factor: 2.150

5.  Clinical potential of resistin as a novel prognostic biomarker for cellulitis.

Authors:  Ayse Erturk; Medine Cumhur Cure; Erkan Cure; Aysel Kurt; Aysegul Copur Cicek; Suleyman Yuce
Journal:  Exp Ther Med       Date:  2015-02-24       Impact factor: 2.447

6.  Essentials in the management of necrotizing soft-tissue infections.

Authors:  Norma Jung; Christian Eckmann
Journal:  Infection       Date:  2019-05-10       Impact factor: 3.553

7.  Local variations in the epidemiology, microbiology, and outcome of necrotizing soft-tissue infections: a multicenter study.

Authors:  Lillian S Kao; Debbie F Lew; Samer N Arab; S Rob Todd; Samir S Awad; Matthew M Carrick; Michael G Corneille; Kevin P Lally
Journal:  Am J Surg       Date:  2011-05-04       Impact factor: 2.565

8.  Outcomes of β-Hemolytic Streptococcal Necrotizing Skin and Soft-tissue Infections and the Impact of Clindamycin Resistance.

Authors:  Dara L Horn; Emma A Roberts; Jolie Shen; Jeannie D Chan; Eileen M Bulger; Noel S Weiss; John B Lynch; Chloe Bryson-Cahn; Bryce R H Robinson
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

9.  Necrotising fasciitis: a ticking time bomb?

Authors:  Carlijn H L van Sambeek; Sander F van Stigt; Lars Brouwers; Mike Bemelman
Journal:  BMJ Case Rep       Date:  2017-10-04

10.  A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections.

Authors:  Peter Matthews; Marc Alpert; Galia Rahav; Denise Rill; Edward Zito; David Gardiner; Ron Pedersen; Timothy Babinchak; Paul C McGovern
Journal:  BMC Infect Dis       Date:  2012-11-12       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.